Forum for health economics & policyHumansPulmonary DiseaseChronic ObstructiveCost-Benefit AnalysisMarkov Chains
Estimating the Value of Ensifentrine in Addition to Background Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease.
Stella M Arndorfer, Elmar R Alizadeh, Kavita Aggarwal, Alex Jones, David C Grabowski
Published: 202510.1515/fhep-2025-0007
Abstract
Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases, leading to increased healthcare use, expenditures, and risk of mortality. In June 2024, the Institute for Clinical and Economic Review (ICER) released a traditional…
Preview only. Read the full abstract at the source